Biomendex

Spain
Castrillón, Asturias, Spain

Company profile

Biomendex company profile

Biomendex develops and manufactures adaptable synthetic bone substitute materials for bone regeneration. Their invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Adaptos® bone graft substitutes are being developed for clinical and veterinary use.

Business identity

Contact email
[email protected]
Phone number
+358405398799
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Country code
ES
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $2.5M / 2019-09-20
Investors
1
Lead investors
1
Founders
3

Founders and investors

Founders

Henna PaakinahoKaarlo PaakinahoMikko Manninen

Lead investors

European Innovation Council

Investors

European Innovation Council